SPI
|
17 036,92
|
54,05
|
0,32 %
|
Analysen zu SPI-Werten
| 01.05.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 01.05.25 | ams-OSRAM Buy | UBS AG | |
| 01.05.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 30.04.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 30.04.25 | Novartis Buy | Deutsche Bank AG | |
| 30.04.25 | Novartis Kaufen | DZ BANK | |
| 30.04.25 | UBS Outperform | RBC Capital Markets | |
| 30.04.25 | ams-OSRAM Buy | Jefferies & Company Inc. | |
| 30.04.25 | UBS Hold | Jefferies & Company Inc. | |
| 30.04.25 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
| 30.04.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 30.04.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 29.04.25 | Novartis Hold | Jefferies & Company Inc. | |
| 29.04.25 | Zurich Insurance Hold | Deutsche Bank AG | |
| 29.04.25 | Novartis Neutral | UBS AG | |
| 29.04.25 | Novartis Outperform | Bernstein Research | |
| 28.04.25 | Roche Sell | Deutsche Bank AG | |
| 28.04.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 25.04.25 | Nestlé Kaufen | DZ BANK | |
| 25.04.25 | Roche Buy | UBS AG | |
| 25.04.25 | Roche Sell | Deutsche Bank AG | |
| 24.04.25 | Nestlé Sector Perform | RBC Capital Markets | |
| 24.04.25 | Roche Kaufen | DZ BANK | |
| 24.04.25 | Richemont Outperform | Bernstein Research | |
| 24.04.25 | Nestlé Neutral | UBS AG | |
| 24.04.25 | Nestlé Market-Perform | Bernstein Research | |
| 24.04.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 24.04.25 | Roche Buy | UBS AG | |
| 24.04.25 | Roche Outperform | Bernstein Research | |
| 24.04.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 24.04.25 | Nestlé Hold | Deutsche Bank AG | |
| 24.04.25 | Nestlé Add | Baader Bank | |
| 24.04.25 | Nestlé Sector Perform | RBC Capital Markets | |
| 24.04.25 | Nestlé Underperform | Jefferies & Company Inc. | |
| 24.04.25 | Roche Hold | Jefferies & Company Inc. | |
| 23.04.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 23.04.25 | ams-OSRAM Buy | UBS AG | |
| 22.04.25 | ABB Sector Perform | RBC Capital Markets | |
| 22.04.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 17.04.25 | Roche Underweight | JP Morgan Chase & Co. |